What is Freeport-McMoRan Inc.'s earnings per share (EPS)?

Freeport-McMoRan Inc. (FCX) reported diluted earnings per share of $1.52 for fiscal year 2025. This represents a 16.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Freeport-McMoRan Inc. (FCX) Financials

FCX

FY2025 annual

Revenue $25.9B +1.8% YoY

Net Income $2.2B +16.7% YoY

EPS (Diluted) $1.52 +16.9% YoY

Free Cash Flow $1.1B -52.6% YoY

Market Cap $104.0B as of Oct 13, 2026

Price / Sales 4.0x on $25.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 34.6x on $3.0B net income, trailing 12 months to June 30, 2026

Price / Book 5.2x on $20.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FCX SEC filings page.

Freeport-McMoRan Inc. (FCX) reported $25.9B in revenue for fiscal year 2025, up 1.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FCX FY2025 2026-10-03

Freeport-McMoRan converts profits into cash, but heavy reinvestment absorbs much of that cash while operating margins remain under pressure.

Net income increased in FY2025 even as operating cash flow and free cash flow declined, so the earnings rebound did not translate into stronger cash creation. Capital expenditures of $4.5B against operating cash flow of $5.6B show why reinvestment absorbed most internally generated cash.

Revenue expanded across FY2023–FY2025 while operating margin narrowed from 27.2% to 25.2%. The latest net-margin recovery to 8.5% therefore came without corresponding improvement in core operating efficiency, pointing to below-operating-line effects rather than stronger operations.

Total liabilities increased from $35.8B in FY2023 to $39.3B in FY2025, yet debt-to-equity declined over that span; equity grew faster than the debt measure, rather than total obligations shrinking. A current ratio above 2.0x in both years indicates near-term obligations were not the main financial constraint.

Financial Health Signals

Financial Health Score 66/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Freeport-McMoRan Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Freeport-McMoRan Inc. has an operating margin of 25.1%, meaning the company retains $25 of operating profit per $100 of revenue. This strong profitability earns a score of 90/100, reflecting efficient cost management and pricing power. This is down from 27.0% the prior year.

Growth

Freeport-McMoRan Inc.'s revenue grew a modest 1.8% year-over-year to $25.9B. This slow but positive growth earns a score of 55/100.

Leverage

Freeport-McMoRan Inc. has a moderate D/E ratio of 0.47. This balance of debt and equity financing earns a leverage score of 57/100.

Liquidity

With a current ratio of 2.29, Freeport-McMoRan Inc. holds $2.29 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.

Cash Flow

Freeport-McMoRan Inc. has a free cash flow margin of 4.3%, earning a moderate score of 46/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Freeport-McMoRan Inc. earns a strong 11.7% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is up from 10.7% the prior year.

Altman Z-Score Grey Zone

2.60

Freeport-McMoRan Inc. scores 2.60, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($104.0B) relative to total liabilities ($39.3B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

Freeport-McMoRan Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.55x

For every $1 of reported earnings, Freeport-McMoRan Inc. generates $2.55 in operating cash flow ($5.6B OCF vs $2.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

17.66x

Freeport-McMoRan Inc. earns $17.66 in operating income for every $1 of interest expense ($6.5B vs $369.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$7.0B

YoY-7.3%

QoQ+12.8%

5Y CAGR+4.1%

10Y CAGR+7.7%

Freeport-McMoRan Inc. generated $7.0B in revenue in Q2 2026. This represents a decrease of 7.3% from the same quarter a year earlier. Against the prior quarter it is up 12.8%.

EBITDA

$2.5B

YoY-18.5%

QoQ-4.7%

5Y CAGR-0.2%

10Y CAGR+14.2%

Freeport-McMoRan Inc.'s EBITDA was $2.5B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 18.5% from the same quarter a year earlier. Against the prior quarter it is down 4.7%.

Net Income

$984.0M

YoY+27.5%

QoQ-29.1%

5Y CAGR-5.9%

Freeport-McMoRan Inc. reported $984.0M in net income in Q2 2026. This represents an increase of 27.5% from the same quarter a year earlier. Against the prior quarter it is down 29.1%.

EPS (Diluted)

$0.68

YoY+28.3%

Freeport-McMoRan Inc. earned $0.68 per diluted share (EPS) in Q2 2026. This represents an increase of 28.3% from the same quarter a year earlier.

Cash & Balance Sheet

Cash & Debt

$4.1B

YoY-9.1%

QoQ+9.2%

5Y CAGR-8.4%

10Y CAGR+28.6%

Freeport-McMoRan Inc. held $4.1B in cash against $8.2B in long-term debt as of Q2 2026.

Dividends Per Share

$0.15

YoY0.0%

5Y CAGR+14.9%

Freeport-McMoRan Inc. paid $0.15 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier.

Shares Outstanding

1.44B

YoY0.0%

5Y CAGR-0.4%

10Y CAGR+0.8%

Freeport-McMoRan Inc. had 1.44B shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Operating Margin

28.5%

YoY-3.6pp

QoQ-5.8pp

5Y change-7.5pp

10Y change+28.0pp

Freeport-McMoRan Inc.'s operating margin was 28.5% in Q2 2026, reflecting core business profitability. This is down 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.8 percentage points.

Net Margin

14.0%

YoY+3.8pp

QoQ-8.2pp

5Y change-9.2pp

10Y change+26.3pp

Freeport-McMoRan Inc.'s net profit margin was 14.0% in Q2 2026, showing the share of revenue converted to profit. This is up 3.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.2 percentage points.

Return on Equity

4.9%

YoY+0.6pp

QoQ-2.2pp

5Y change-6.2pp

10Y change+15.1pp

Freeport-McMoRan Inc.'s ROE was 4.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.2 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$110.0M

YoY+111.5%

QoQ+18.3%

Freeport-McMoRan Inc. spent $110.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 111.5% from the same quarter a year earlier. Against the prior quarter it is up 18.3%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

FCX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$25.9B	$25.9B+1.8%	$25.5B+11.4%	$22.9B+0.3%	$22.8B-0.3%	$22.8B+60.9%	$14.2B-1.4%	$14.4B-22.7%	$18.6B+13.6%	$16.4B+10.6%	$14.8B+1.5%	$14.6B-27.0%	$20.0B+3.5%	$19.3B+7.3%	$18.0B-13.7%	$20.9B
Cost of Revenue	$18.9B	$18.6B+4.6%	$17.8B+13.4%	$15.7B+4.0%	$15.1B+7.5%	$14.0B+20.4%	$11.7B-11.2%	$13.1B-2.5%	$13.5B+12.4%	$12.0B-31.7%	$17.5B-36.0%	$27.4B+48.2%	$18.5B+35.7%	$13.6B+17.9%	$11.6B+5.9%	$10.9B
SG&A Expenses	$561.0M	$545.0M+6.2%	$513.0M+7.1%	$479.0M+14.0%	$420.0M+9.7%	$383.0M+3.5%	$370.0M-6.1%	$394.0M-6.6%	$422.0M-11.5%	$477.0M-20.1%	$597.0M+7.0%	$558.0M-3.8%	$580.0M-10.1%	$645.0M+49.7%	$431.0M+3.9%	$415.0M
Operating Income	$6.9B	$6.5B-5.0%	$6.9B+10.3%	$6.2B-11.5%	$7.0B-15.9%	$8.4B+243.3%	$2.4B+123.4%	$1.1B-77.1%	$4.8B+28.8%	$3.7B+235.2%	-$2.7B+79.8%	-$13.5B-4434.2%	-$298.0M-106.2%	$4.8B-17.1%	$5.8B-36.4%	$9.1B
EBITDA	N/A	$8.8B-3.8%	$9.1B+9.8%	$8.3B-8.4%	$9.1B-12.6%	$10.4B+161.4%	$4.0B+58.4%	$2.5B-61.5%	$6.5B+20.4%	$5.4B+4641.2%	-$119.0M+98.8%	-$10.0B-380.9%	$3.6B-53.2%	$7.6B	N/A	N/A
Interest Expense	-$426.0M	-$369.0M-15.7%	-$319.0M+38.1%	-$515.0M+8.0%	-$560.0M+7.0%	-$602.0M-0.7%	-$598.0M+3.5%	-$620.0M+34.4%	-$945.0M-18.0%	-$801.0M-6.1%	-$755.0M-22.4%	-$617.0M-1.8%	-$606.0M	N/A	N/A	$312.0M
Income Tax	$2.1B	$2.2B-12.0%	$2.5B+11.1%	$2.3B+0.1%	$2.3B-1.4%	$2.3B+143.5%	$944.0M+85.1%	$510.0M-48.5%	$991.0M+12.2%	$883.0M+138.0%	$371.0M+119.0%	-$2.0B-967.1%	$225.0M-83.2%	$1.3B-11.3%	$1.5B-51.1%	$3.1B
Net Income	$3.0B	$2.2B+16.7%	$1.9B+2.2%	$1.8B-46.7%	$3.5B-19.5%	$4.3B+397.8%	$865.0M+557.7%	-$189.0M-106.5%	$2.9B+38.1%	$2.1B+152.0%	-$4.0B+66.7%	-$12.1B-1522.7%	-$745.0M-121.7%	$3.4B-13.5%	$4.0B-30.7%	$5.7B
EPS (Basic)	N/A	$1.53+16.8%	$1.31+2.3%	$1.28-46.7%	$2.40-18.1%	$2.93+614.6%	$0.41+341.2%	-$0.17-109.5%	$1.79+43.2%	$1.25+139.6%	-$3.16+72.1%	-$11.31-797.6%	-$1.26-147.5%	$2.65-17.2%	$3.20-33.5%	$4.81
EPS (Diluted)	—	$1.52+16.9%	$1.30+1.6%	$1.28-46.4%	$2.39-17.6%	$2.90+607.3%	$0.41	-$0.17-109.6%	$1.78+42.4%	$1.25+139.6%	-$3.16+72.1%	-$11.31	-$1.26	$2.64-17.2%	$3.19-33.3%	$4.78
Diluted Shares (Avg)	N/A	1.44B-0.1%	1.45B+0.1%	1.44B-0.6%	1.45B-2.1%	1.48B+1.4%	1.46B	1.45B-0.5%	1.46B+0.3%	1.45B+10.3%	1.32B+21.8%	1.08B	1.04B	1.01B+5.5%	954M-0.1%	955M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$7.0B-7.3%	$6.2B+8.8%	$5.6B-1.5%	$7.0B+2.7%	$7.6B+14.5%	$5.7B-9.4%	$5.7B-3.1%	$6.8B+16.6%
Cost of Revenue	$4.8B-2.2%	$4.6B+8.5%	$4.6B+7.5%	$4.8B+3.3%	$5.0B+12.9%	$4.2B-4.9%	$4.3B+8.8%	$4.7B+14.5%
SG&A Expenses	$135.0M+6.3%	$162.0M+5.2%	$133.0M+3.1%	$131.0M+12.0%	$127.0M+3.3%	$154.0M+6.9%	$129.0M+7.5%	$117.0M-0.8%
Operating Income	$2.0B-17.6%	$2.1B+64.0%	$811.0M-34.8%	$2.0B+1.8%	$2.4B+18.7%	$1.3B-20.3%	$1.2B-27.8%	$1.9B+29.9%
EBITDA	$2.5B-18.5%	$2.7B+49.9%	$1.3B-27.2%	$2.6B+2.3%	$3.1B+21.2%	$1.8B-20.6%	$1.8B-23.0%	$2.5B+25.3%
Interest Expense	-$95.0M-15.9%	-$114.0M-62.9%	-$110.0M-57.1%	-$107.0M-48.6%	-$82.0M+6.8%	-$70.0M+21.3%	-$70.0M+27.8%	-$72.0M+25.0%
Income Tax	$544.0M-36.0%	$653.0M+30.6%	$202.0M-61.2%	$669.0M-9.2%	$850.0M+12.7%	$500.0M-2.3%	$520.0M-28.2%	$737.0M+45.1%
Net Income	$984.0M+27.5%	$1.4B+74.9%	-$608.0M+66.0%	$1.2B+0.9%	$772.0M-39.7%	$793.0M-31.8%	-$1.8B-99.7%	$1.2B+28.2%
EPS (Basic)	$0.68+28.3%	$0.61+154.2%	N/A	$0.46+27.8%	$0.53+26.2%	$0.24-27.3%	N/A	$0.36+16.1%
EPS (Diluted)	$0.68+28.3%	$0.61+154.2%	N/A	$0.46+27.8%	$0.53	$0.24-25.0%	N/A	$0.36+16.1%
Diluted Shares (Avg)	1.44B0.0%	1.44B0.0%	N/A	1.44B-0.1%	1.44B	1.44B0.0%	N/A	1.44B+0.1%

Not reported in any period shown, so not listed: Gross Profit, R&D Expenses.

FCX Balance Sheet

FCX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$58.2B+6.1%	$54.8B+4.5%	$52.5B+2.8%	$51.1B+6.4%	$48.0B+13.9%	$42.1B+3.3%	$40.8B-3.3%	$42.2B+13.2%	$37.3B0.0%	$37.3B-19.9%	$46.6B-20.6%	$58.7B-7.4%	$63.4B+78.9%	$35.4B+10.5%	$32.1B
Current Assets	$13.8B+3.7%	$13.3B-5.5%	$14.1B-9.9%	$15.6B+5.3%	$14.8B+59.4%	$9.3B+17.5%	$7.9B-24.4%	$10.5B-1.5%	$10.6B+1.8%	$10.4B+39.8%	$7.5B-17.5%	$9.0B-9.3%	$10.0B-3.2%	$10.3B+2.5%	$10.0B
Cash & Equivalents	$3.8B-2.5%	$3.9B-17.5%	$4.8B-41.6%	$8.1B+1.0%	$8.1B+120.6%	$3.7B+81.0%	$2.0B-52.1%	$4.2B-6.8%	$4.5B+6.6%	$4.2B+2298.3%	$177.0M-40.6%	$298.0M-84.0%	$1.9B-47.8%	$3.6B-26.0%	$4.8B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	$1.8B+52.4%	$1.2B+26.1%	$927.0M+24.4%	$745.0M-11.2%	$839.0M-36.7%	$1.3B+34.6%	$985.0M+56.6%	$629.0M-0.6%	$633.0M-32.0%	$931.0M-81.4%	$5.0B+450.8%	$911.0M	N/A
Accounts Receivable	$977.0M+69.0%	$578.0M-52.2%	$1.2B-9.5%	$1.3B+14.4%	$1.2B+30.9%	$892.0M+20.4%	$741.0M-10.6%	$829.0M-37.3%	$1.3B+17.4%	$1.1B+74.6%	$645.0M-31.4%	$940.0M-45.6%	$1.7B+86.4%	$927.0M+3.9%	$892.0M
Long-Term Investments	$125.0M+22.5%	$102.0M+21.4%	$84.0M+6.3%	$79.0M+6.8%	$74.0M+5.7%	$70.0M+6.1%	$66.0M+1.5%	$65.0M+116.7%	$30.0M-40.0%	$50.0M+6.4%	$47.0M+2.2%	$46.0M+4.5%	$44.0M-4.3%	$46.0M+411.1%	$9.0M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$1.9B	$0	N/A
Total Liabilities	$39.3B+5.4%	$37.3B+4.1%	$35.8B+36.6%	$26.2B+4.9%	$25.0B-21.8%	$32.0B+36.9%	$23.4B-4.0%	$24.3B-6.5%	$26.0B-7.3%	$28.1B-16.9%	$33.8B-4.7%	$35.4B-5.5%	$37.5B+165.6%	$14.1B+4.5%	$13.5B
Current Liabilities	$6.0B+9.5%	$5.5B-5.5%	$5.8B-8.4%	$6.3B+7.7%	$5.9B+72.4%	$3.4B+6.5%	$3.2B-3.6%	$3.3B-32.3%	$4.9B+15.2%	$4.3B-1.0%	$4.3B-16.7%	$5.2B+8.4%	$4.8B+42.8%	$3.3B+13.7%	$2.9B
Non-Current Liabilities	$33.2B+4.7%	$31.8B+5.9%	$30.0B+50.9%	$19.9B+4.0%	$19.1B-33.1%	$28.6B+41.7%	$20.2B-4.0%	$21.0B-0.5%	$21.1B-11.4%	$23.8B-19.2%	$29.5B-2.7%	$30.3B-7.6%	$32.8B+203.7%	$10.8B+2.0%	$10.6B
Long-Term Debt	$8.9B+0.1%	$8.9B+2.9%	$8.7B-9.7%	$9.6B+5.6%	$9.1B-6.2%	$9.7B-1.5%	$9.8B-11.7%	$11.1B-5.8%	$11.8B-20.1%	$14.8B-24.8%	$19.7B+7.1%	$18.4B-9.9%	$20.4B+478.6%	$3.5B-0.2%	$3.5B
Total Equity	$18.9B+7.5%	$17.6B+5.3%	$16.7B+7.3%	$15.6B+11.3%	$14.0B+37.4%	$10.2B+9.4%	$9.3B-5.1%	$9.8B+22.8%	$8.0B+31.8%	$6.1B-22.7%	$7.8B-57.2%	$18.3B-12.6%	$20.9B+19.3%	$17.5B+12.2%	$15.6B
Retained Earnings	$1.4B+914.7%	-$170.0M+91.7%	-$2.1B+47.3%	-$3.9B+47.0%	-$7.4B+36.9%	-$11.7B+4.9%	-$12.3B-2.0%	-$12.0B+18.2%	-$14.7B+11.0%	-$16.5B-33.5%	-$12.4B-9777.3%	$128.0M-95.3%	$2.7B+14.3%	$2.4B+339.4%	$546.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$59.7B+5.7%	$58.8B+5.0%	$58.2B+6.1%	$56.8B+2.6%	$56.5B+3.4%	$56.0B+3.4%	$54.8B+4.5%	$55.4B+7.3%
Current Assets	$14.2B+3.9%	$14.1B+2.1%	$13.8B+3.7%	$13.6B-6.7%	$13.6B-7.4%	$13.8B-7.0%	$13.3B-5.5%	$14.5B+3.3%
Cash & Equivalents	$4.1B-9.1%	$3.7B-14.8%	$3.8B-2.5%	$4.3B-13.6%	$4.5B-14.8%	$4.4B-15.8%	$3.9B-17.5%	$5.0B-13.0%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$716.0M-23.9%	$681.0M-8.3%	$977.0M+69.0%	$916.0M-6.4%	$941.0M-16.6%	$743.0M-50.3%	$578.0M-52.2%	$979.0M+23.6%
Long-Term Investments	$0	$0	$125.0M+22.5%	$0	$0	$0	$102.0M+21.4%	$0
Total Liabilities	$39.6B+3.5%	$39.3B+2.6%	$39.3B+5.4%	$38.1B+0.8%	$38.3B+2.8%	$38.3B+3.0%	$37.3B+4.1%	$37.9B+51.6%
Current Liabilities	$6.9B+24.0%	$5.9B-0.6%	$6.0B+9.5%	$5.5B-11.5%	$5.5B-9.9%	$5.9B-5.7%	$5.5B-5.5%	$6.2B+28.5%
Non-Current Liabilities	$32.8B0.0%	$33.4B+3.2%	$33.2B+4.7%	$32.6B+3.2%	$32.8B+5.3%	$32.4B+4.8%	$31.8B+5.9%	$31.6B+57.2%
Long-Term Debt	$8.2B-8.4%	$8.9B+0.1%	$8.9B+0.1%	$8.9B+0.1%	$8.9B+2.9%	$8.9B+2.9%	$8.9B+2.9%	$8.9B-4.9%
Total Equity	$20.1B+10.4%	$19.5B+10.3%	$18.9B+7.5%	$18.7B+6.5%	$18.2B+4.6%	$17.7B+4.2%	$17.6B+5.3%	$17.5B+6.6%
Retained Earnings	$2.8B+281.7%	$2.0B+1026.4%	$1.4B+914.7%	$1.2B+369.4%	$738.0M+176.1%	$182.0M+111.5%	-$170.0M+91.7%	-$444.0M+81.9%

Not reported in any period shown, so not listed: Inventory, Goodwill.

FCX Cash Flow Statement

FCX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$5.9B	$5.6B-21.6%	$7.2B+35.6%	$5.3B+2.7%	$5.1B-33.4%	$7.7B+155.7%	$3.0B+103.6%	$1.5B-61.6%	$3.9B-17.2%	$4.7B+24.9%	$3.7B+16.1%	$3.2B-42.8%	$5.6B-8.3%	$6.1B+62.7%	$3.8B-43.0%	$6.6B
Depreciation & Amortization	N/A	$2.2B+0.1%	$2.2B+8.4%	$2.1B+2.4%	$2.0B+1.1%	$2.0B+30.8%	$1.5B+8.2%	$1.4B-19.5%	$1.8B+2.3%	$1.7B-34.3%	$2.6B-25.4%	$3.5B-9.5%	$3.9B+38.1%	$2.8B	N/A	N/A
Stock-Based Compensation	N/A	$121.0M+11.0%	$109.0M0.0%	$109.0M+14.7%	$95.0M-3.1%	$98.0M-1.0%	$99.0M+57.1%	$63.0M-17.1%	$76.0M+7.0%	$71.0M-17.4%	$86.0M+1.2%	$85.0M-19.8%	$106.0M-38.7%	$173.0M+73.0%	$100.0M-14.5%	$117.0M
Capital Expenditures	N/A	$4.5B-6.5%	$4.8B-0.3%	$4.8B+39.1%	$3.5B+64.0%	$2.1B+7.9%	$2.0B-26.1%	$2.7B+34.6%	$2.0B+39.8%	$1.4B-49.9%	$2.8B-55.7%	$6.4B-11.9%	$7.2B+36.5%	$5.3B+51.3%	$3.5B+37.9%	$2.5B
Free Cash Flow	N/A	$1.1B-52.6%	$2.4B+416.9%	$455.0M-72.8%	$1.7B-70.2%	$5.6B+430.3%	$1.1B+190.3%	-$1.2B-161.8%	$1.9B-41.9%	$3.3B+252.4%	$924.0M+129.5%	-$3.1B-97.8%	-$1.6B-285.7%	$853.0M+204.6%	$280.0M-93.1%	$4.1B
Investing Cash Flow	-$4.2B	-$4.5B+11.1%	-$5.0B-1.5%	-$5.0B-44.1%	-$3.4B-75.2%	-$2.0B-55.4%	-$1.3B+39.9%	-$2.1B+58.1%	-$5.0B-279.9%	-$1.3B-137.2%	$3.6B+156.9%	-$6.2B-64.3%	-$3.8B+65.2%	-$10.9B-215.0%	-$3.5B-36.6%	-$2.5B
Financing Cash Flow	-$2.0B	-$1.9B+42.9%	-$3.3B-23.9%	-$2.6B-63.3%	-$1.6B-21.1%	-$1.3B-946.9%	-$128.0M+91.8%	-$1.6B-272.9%	$900.0M+129.5%	-$3.1B+3.5%	-$3.2B-213.6%	$2.8B+183.1%	-$3.4B-209.9%	$3.0B+313.5%	-$1.4B+52.4%	-$3.0B
Dividends Paid	$866.0M	$865.0M0.0%	$865.0M+0.2%	$863.0M-0.3%	$866.0M-13.4%	$1.0B	$0	$0-100.0%	$496.0M+181.8%	$176.0M-74.8%	$699.0M-3.6%	$725.0M-58.1%	$1.7B-31.8%	$2.5B+124.7%	$1.1B-20.7%	$1.4B
Share Buybacks	$203.0M	$107.0M+81.4%	$59.0M	$0-100.0%	$1.3B+176.0%	$488.0M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$2.0B-6.7%	$1.5B+41.3%	$693.0M-51.7%	$1.7B-11.1%	$2.2B+12.2%	$1.1B-44.2%	$1.4B+8.8%	$1.9B+51.5%
Depreciation & Amortization	$523.0M-21.7%	$514.0M+10.3%	$485.0M-9.7%	$625.0M+4.2%	$668.0M+31.2%	$466.0M-21.7%	$537.0M-8.8%	$600.0M+12.6%
Stock-Based Compensation	N/A	$68.0M+25.9%	N/A	N/A	N/A	$54.0M+1.9%	N/A	N/A
Capital Expenditures	N/A	$973.0M-17.0%	$1.0B-18.9%	$1.1B-11.9%	$1.3B+13.0%	$1.2B-6.5%	$1.2B-9.0%	$1.2B+1.8%
Free Cash Flow	N/A	$522.0M+557.9%	-$312.0M-258.4%	$608.0M-9.7%	$934.0M+11.2%	-$114.0M-117.8%	$197.0M+569.0%	$673.0M+1060.3%
Investing Cash Flow	-$1.2B+5.1%	-$985.0M+16.2%	-$1.0B+16.3%	-$1.0B+28.5%	-$1.3B-13.4%	-$1.2B+7.9%	-$1.2B+10.3%	-$1.4B-15.8%
Financing Cash Flow	-$514.0M+51.6%	-$534.0M-444.5%	-$143.0M+90.5%	-$825.0M-27.7%	-$1.1B-35.2%	$155.0M+145.3%	-$1.5B-256.1%	-$646.0M-56.0%
Dividends Paid	$216.0M+0.5%	$218.0M0.0%	$216.0M0.0%	$216.0M-73.0%	$215.0M0.0%	$218.0M0.0%	$216.0M0.0%	$800.0M+141.0%
Share Buybacks	$110.0M+111.5%	$93.0M+69.1%	$0	$0-100.0%	$52.0M	$55.0M	$0	$59.0M

FCX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	25.1%-1.8pp	27.0%-0.3pp	27.2%-3.7pp	30.9%-5.7pp	36.6%+19.5pp	17.2%+9.6pp	7.6%-17.9pp	25.5%+3.0pp	22.5%+40.9pp	-18.4%+74.1pp	-92.5%-91.0pp	-1.5%-26.4pp	24.9%-7.3pp	32.3%-11.5pp	43.8%
Net Margin	8.5%+1.1pp	7.4%-0.7pp	8.1%-7.1pp	15.2%-3.6pp	18.9%+12.8pp	6.1%+7.4pp	-1.3%-16.9pp	15.5%+2.8pp	12.8%+39.9pp	-27.1%+55.6pp	-82.8%-79.0pp	-3.7%-21.5pp	17.8%-4.3pp	22.1%-5.4pp	27.5%
Return on Equity	11.7%+0.9pp	10.7%-0.3pp	11.1%-11.2pp	22.3%-8.5pp	30.8%+22.3pp	8.5%+10.5pp	-2.0%-31.6pp	29.5%+3.3pp	26.3%+92.8pp	-66.5%+87.9pp	-154.4%-150.4pp	-4.1%-20.5pp	16.4%-6.3pp	22.7%-14.1pp	36.7%
Return on Assets	3.8%+0.4pp	3.4%-0.1pp	3.5%-3.3pp	6.8%-2.2pp	9.0%+6.9pp	2.1%+2.5pp	-0.5%-7.3pp	6.9%+1.2pp	5.6%+16.4pp	-10.8%+15.2pp	-25.9%-24.7pp	-1.3%-6.7pp	5.4%-5.8pp	11.2%-6.7pp	17.9%
Current Ratio	2.29-0.1x	2.420.0x	2.420.0x	2.46-0.1x	2.52-0.2x	2.72+0.3x	2.47-0.7x	3.14+1.0x	2.16-0.3x	2.45+0.7x	1.730.0x	1.75-0.3x	2.09-1.0x	3.08-0.3x	3.42
Debt-to-Equity	0.470.0x	0.510.0x	0.52-0.1x	0.620.0x	0.65-0.3x	0.95-0.1x	1.06-0.1x	1.14-0.3x	1.48-1.0x	2.45-0.1x	2.51+1.5x	1.000.0x	0.97+0.8x	0.200.0x	0.23
Asset Turnover	0.450.0x	0.460.0x	0.440.0x	0.450.0x	0.48+0.1x	0.340.0x	0.35-0.1x	0.440.0x	0.440.0x	0.40+0.1x	0.310.0x	0.340.0x	0.30-0.2x	0.51-0.1x	0.65
FCF Margin	4.3%-4.9pp	9.2%+7.2pp	2.0%-5.3pp	7.3%-17.2pp	24.5%+17.1pp	7.4%+15.6pp	-8.1%-18.3pp	10.2%-9.7pp	19.9%+13.6pp	6.2%+27.7pp	-21.4%-13.5pp	-7.9%-12.3pp	4.4%+2.9pp	1.6%-18.0pp	19.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	28.5%-3.6pp	34.3%+11.5pp	14.4%-7.3pp	28.3%-0.3pp	32.1%+1.1pp	22.8%-3.1pp	21.7%-7.4pp	28.5%+2.9pp
Net Margin	14.0%+3.8pp	22.3%+8.4pp	-10.8%+20.5pp	17.9%-0.3pp	10.2%-9.1pp	13.8%-4.5pp	-31.3%-16.1pp	18.2%+1.6pp
Return on Equity	4.9%+0.6pp	7.1%+2.6pp	-3.2%+7.0pp	6.7%-0.4pp	4.2%-3.1pp	4.5%-2.4pp	-10.2%-4.8pp	7.0%+1.2pp
Return on Assets	1.7%+0.3pp	2.4%+0.9pp	-1.1%+2.2pp	2.2%0.0pp	1.4%-1.0pp	1.4%-0.7pp	-3.3%-1.5pp	2.2%+0.4pp
Current Ratio	2.07-0.4x	2.39+0.1x	2.29-0.1x	2.45+0.1x	2.47+0.1x	2.320.0x	2.420.0x	2.33-0.6x
Debt-to-Equity	0.41-0.1x	0.460.0x	0.470.0x	0.480.0x	0.490.0x	0.500.0x	0.510.0x	0.51-0.1x
Asset Turnover	0.120.0x	0.110.0x	0.100.0x	0.120.0x	0.130.0x	0.100.0x	0.100.0x	0.120.0x
FCF Margin	N/A	8.4%+10.4pp	-5.5%-9.0pp	8.7%-1.2pp	12.3%-0.4pp	-2.0%-12.2pp	3.4%+4.2pp	9.9%+8.9pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Freeport-McMoRan Inc. FCX	FY2025	$25.9B	$2.2B	8.5%	$104.0B	66/100
Hudbay Minerals Inc. HBM	FY2025	$2.2B	$564.3M	25.5%	$11.4B	42/100
Ero Copper Corp. ERO	FY2025	$785.8M	$266.9M	34.0%	$3.9B	35/100
Ivanhoe Electric Inc. IE	FY2025	$3.2M	-$105.9M	N/A	$1.5B	46/100

Where Freeport-McMoRan Inc. Ranks

Frequently Asked Questions

What is Freeport-McMoRan Inc.'s annual revenue?

Freeport-McMoRan Inc. (FCX) reported $25.9B in total revenue for fiscal year 2025. This represents a 1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Freeport-McMoRan Inc.'s revenue growing?

Freeport-McMoRan Inc. (FCX) revenue grew by 1.8% year-over-year, from $25.5B to $25.9B in fiscal year 2025.

Is Freeport-McMoRan Inc. profitable?

Yes, Freeport-McMoRan Inc. (FCX) reported a net income of $2.2B in fiscal year 2025, with a net profit margin of 8.5%.

What is Freeport-McMoRan Inc.'s EBITDA?

Freeport-McMoRan Inc. (FCX) had EBITDA of $8.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Freeport-McMoRan Inc. have?

As of fiscal year 2025, Freeport-McMoRan Inc. (FCX) had $3.8B in cash and equivalents against $8.9B in long-term debt.

What is Freeport-McMoRan Inc.'s operating margin?

Freeport-McMoRan Inc. (FCX) had an operating margin of 25.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Freeport-McMoRan Inc.'s net profit margin?

Freeport-McMoRan Inc. (FCX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Freeport-McMoRan Inc. pay dividends?

Yes, Freeport-McMoRan Inc. (FCX) paid $0.60 per share in dividends during fiscal year 2025.

What is Freeport-McMoRan Inc.'s return on equity (ROE)?

Freeport-McMoRan Inc. (FCX) has a return on equity of 11.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Freeport-McMoRan Inc.'s free cash flow?

Freeport-McMoRan Inc. (FCX) generated $1.1B in free cash flow during fiscal year 2025. This represents a -52.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Freeport-McMoRan Inc.'s operating cash flow?

Freeport-McMoRan Inc. (FCX) generated $5.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Freeport-McMoRan Inc.'s total assets?

Freeport-McMoRan Inc. (FCX) had $58.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Freeport-McMoRan Inc.'s capital expenditures?

Freeport-McMoRan Inc. (FCX) invested $4.5B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Freeport-McMoRan Inc. buy back shares?

Yes, Freeport-McMoRan Inc. (FCX) spent $107.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Freeport-McMoRan Inc. have outstanding?

Freeport-McMoRan Inc. (FCX) had 1.44B shares outstanding as of fiscal year 2025.

What is Freeport-McMoRan Inc.'s current ratio?

Freeport-McMoRan Inc. (FCX) had a current ratio of 2.29 as of fiscal year 2025, which is generally considered healthy.

What is Freeport-McMoRan Inc.'s debt-to-equity ratio?

Freeport-McMoRan Inc. (FCX) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Freeport-McMoRan Inc.'s return on assets (ROA)?

Freeport-McMoRan Inc. (FCX) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Freeport-McMoRan Inc.'s P/E ratio?

Freeport-McMoRan Inc. (FCX) trades at 34.6x earnings, its market capitalization divided by net income of $3.0B net income, trailing 12 months to June 30, 2026. The market capitalization is $104.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Freeport-McMoRan Inc.'s price-to-sales ratio?

Freeport-McMoRan Inc. (FCX) trades at 4.0x sales, its market capitalization divided by revenue of $25.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $104.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Freeport-McMoRan Inc.'s Altman Z-Score?

Freeport-McMoRan Inc. (FCX) has an Altman Z-Score of 2.60, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Freeport-McMoRan Inc.'s Piotroski F-Score?

Freeport-McMoRan Inc. (FCX) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Freeport-McMoRan Inc.'s earnings high quality?

Freeport-McMoRan Inc. (FCX) has an earnings quality ratio of 2.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Freeport-McMoRan Inc. cover its interest payments?

Freeport-McMoRan Inc. (FCX) has an interest coverage ratio of 17.66x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Freeport-McMoRan Inc.?

Freeport-McMoRan Inc. (FCX) scores 66 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.